FindTrial
Sign In

Clinical effect of Mudan granule on diabetic microvascular complication.

Study on the comorbidity mechanism of Mudan granule to improve diabetic microangiopathy based on the collateral disease theory

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800015179
Enrollment
Unknown
Registered
2018-03-12
Start date
2019-03-12
Completion date
Unknown
Last updated
2018-03-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

diabetic microvascular complication

Interventions

DKD-CHM group:Diovan
DKD-WT group:Diovan
DKD-CHM group:Mudan granule
DKD-Combind group:Diovan and Mudan granule

Sponsors

Metabolic Diseases Hospital & Tianjin Institute of Endocrinology, Tianjin Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: DKD: 1. Type 2 diabetes; 2. Aged 35-75 years; 3. Glucostasis, systolic pressure<130mm Hg, diastolic blood pressure<80mm Hg and HbA1c=6.5%; 4. Urinary protein ACR; 30-300ug/gCr; 5. Inform Consent Form; 6. Voluntary participation. NPDR: 1. DR; 2. NPDR; 3. Aged 35-75 years; 4. Stolic pressure<130mm Hg, diastolic blood pressure<80mm Hg and HbA1c=6.5%; 5. Inform Consent Form; 6. Voluntary participation.

Exclusion criteria

Exclusion criteria: 1. Type 1 diabetes; 2. Malignant tumor; 3. Histoty of renal diseases; 4. History of immune disease; 5. Cardiac insufficiency; 6. History of cardiopathy; 7. Immune deficiency; 8. Organ transplantation or HIV; 9. Women with pregnancy or lactation.

Design outcomes

Primary

MeasureTime frame
effective rate;Traditional Chinese medicine symptom;—

Contacts

Public ContactLiming Chen

Metabolic Diseases Hospital & Tianjin Institute of Endocrinology, Tianjin Medical University

xfx22081@vip.163.com+86 13920979401

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026